Hyundai Pharmaceutical

004310 · KOSPI · Health Care · SMALL CAP

Updated terms.

Hyundai Pharmaceutical updated a disclosed plan to sell treasury shares worth US$42.8M, about 23.2% of its market value.

Treasury Shares([Amended] Material event report (treasury share disposal))· FILED 2026-02-27· RCEPT 20260226007231

US$42.8MDisposal amount
23.2%vs. market value

Converted at 1 USD ≈ ₩1,432.32 (filing-date rate, 2026-02-27 close)

What happened

Hyundai Pharmaceutical updated a disclosed plan to sell treasury shares worth US$42.8M, about 23.2% of its market value.

For context, this equals about 23.2% of the company's market value.

Disposal amountUS$42.8M
vs. market value23.2%
Filed2026-02-27, [Amended] Material event report (treasury share disposal)
SourceDART rcept 20260226007231 → open original filing

Versions of this filing

  1. 2026-02-26Original
  2. 2026-02-27Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-27 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.